To track the patient's heart rate, implantable defibrillators—tiny, battery-operated devices—are positioned beneath the patient's chest or abdomen. When palpitations increase, the device notices this and restarts the heartbeat normally. In individuals who have chronic ventricular tachycardia or atrial fibrillation, these devices are essential for preventing sudden cardiac arrest. ICDs use electrodes to continuously monitor the heart rhythm and, if an abnormal rhythm is discovered, to give treatments.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product Type (Single Chambered Implantable Defibrillators, Dual Chambered Implantable Defibrillators, Biventricular Implantable Defibrillators), Procedure Type (Trans-Venous Implantable Defibrillators, Subcutaneous Implantable Defibrillators), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Industry Trends and Forecast to 2032
.
The Global Implantable Defibrillators Market size was valued at USD 2.74 USD Billion in 2024.
The Global Implantable Defibrillators Market is projected to grow at a CAGR of 7.25% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
